The synergistic effect of co-inhibiting p110 and AKT isoforms may reflect incomplete inhibition of each part of a linear PI3K-AKT pathway, but it is also consistent with previous studies showing AKT-independent functions for PI3K [82] and PI3K-independent AKT roles in cancer [83]. Here, PIK3CB is linked to cancer.